Headlands Technologies LLC Applied Therapeutics Inc. Transaction History
Headlands Technologies LLC
- $939 Million
- Q4 2024
A detailed history of Headlands Technologies LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 23 shares of APLT stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$13% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$6.79 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$5.89 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$5.67 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$5.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$5.17 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $28.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...